Search research articles
Contact Us
Filters
Showing results (1-10 of 94) with videos related to
Page
of 10
Sort By:
Journal of Crohn'S & Colitis
|
June 23, 2022
Serum Monitoring of Recurrence in Post-Operative Crohn's Disease: Have We Arrived?
Robert Battat
Crohn'S & Colitis 360
|
February 13, 2023
Therapeutic Drug Monitoring of Certolizumab Pegol: Can Real-World Data Translate to Clinical Practice?
Robert Battat
Alimentary Pharmacology & Therapeutics
|
February 27, 2020
Editorial: calcineurin inhibitors as a bridge to vedolizumab for severe ulcerative colitis
Robert Battat
Inflammatory Bowel Diseases
|
May 5, 2022
Authors' Reply to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease"
Robert Battat
World Journal of Gastroenterology
|
March 23, 2022
Machine learning models and over-fitting considerations
Paris Charilaou, Robert Battat
The Lancet. Gastroenterology & Hepatology
|
December 14, 2024
Intensified infliximab induction therapy for steroid-refractory acute severe ulcerative colitis
Diana Coman, Robert Battat
Journal of Clinical Medicine
|
May 27, 2023
Therapeutic Drug Monitoring of Infliximab in Acute Severe Ulcerative Colitis
Benjamin L Gordon, Robert Battat
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 5, 2021
Advances in the Comprehensive Management of Postoperative Crohn's Disease
Robert Battat, William J Sandborn
The American Journal of Gastroenterology
|
September 13, 2021
Is Proactive Therapeutic Drug Monitoring Ready for the Spotlight in Inflammatory Bowel Disease? Follow the Data
Robert Battat, Millie D Long
World Journal of Gastroenterology
|
August 9, 2017
Management of inflammatory bowel disease with <i>Clostridium difficile</i> infection
Julie D'Aoust, Robert Battat, Talat Bessissow
Page
of 10
Search research articles
Search
Showing results (1-10 of 94) with videos related to
Sort By:
Page
of 10
Journal of Crohn'S & Colitis
|
June 23, 2022
Serum Monitoring of Recurrence in Post-Operative Crohn's Disease: Have We Arrived?
Robert Battat
Crohn'S & Colitis 360
|
February 13, 2023
Therapeutic Drug Monitoring of Certolizumab Pegol: Can Real-World Data Translate to Clinical Practice?
Robert Battat
Alimentary Pharmacology & Therapeutics
|
February 27, 2020
Editorial: calcineurin inhibitors as a bridge to vedolizumab for severe ulcerative colitis
Robert Battat
Inflammatory Bowel Diseases
|
May 5, 2022
Authors' Reply to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease"
Robert Battat
World Journal of Gastroenterology
|
March 23, 2022
Machine learning models and over-fitting considerations
Paris Charilaou, Robert Battat
The Lancet. Gastroenterology & Hepatology
|
December 14, 2024
Intensified infliximab induction therapy for steroid-refractory acute severe ulcerative colitis
Diana Coman, Robert Battat
Journal of Clinical Medicine
|
May 27, 2023
Therapeutic Drug Monitoring of Infliximab in Acute Severe Ulcerative Colitis
Benjamin L Gordon, Robert Battat
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 5, 2021
Advances in the Comprehensive Management of Postoperative Crohn's Disease
Robert Battat, William J Sandborn
The American Journal of Gastroenterology
|
September 13, 2021
Is Proactive Therapeutic Drug Monitoring Ready for the Spotlight in Inflammatory Bowel Disease? Follow the Data
Robert Battat, Millie D Long
World Journal of Gastroenterology
|
August 9, 2017
Management of inflammatory bowel disease with <i>Clostridium difficile</i> infection
Julie D'Aoust, Robert Battat, Talat Bessissow
Page
of 10